EGFR and cervical cancer: Therefore, the activation of the EGFR/AKT2/CCND1 signaling pathway induced by HPV16 E6-deprivated miR-2861 expression in cervical cancer cells may, at least partially, explain the tumor suppression effects of miR-2861 in cervical cancer.